Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2018, Article ID 6798238, 8 pages
https://doi.org/10.1155/2018/6798238
Research Article

Low-Level Laser Therapy Reduces Lung Inflammation in an Experimental Model of Chronic Obstructive Pulmonary Disease Involving P2X7 Receptor

1Post Graduate Program in Biophotonics Applied to Health Sciences, University Nove de Julho (UNINOVE), Sao Paulo, SP, Brazil
2Brazilian Institute of Teaching and Research in Pulmonary and Exercise Immunology (IBEPIPE), São José dos Campos, SP, Brazil
3Experimental Cardiorespiratory Physiology Laboratory, Master’s Degree and PhD Program in Rehabilitation Sciences, University Nove de Julho (UNINOVE), Sao Paulo, SP, Brazil
4Division of Trauma, Surgical Critical Care, Burns, and Acute Care Surgery, Department of Surgery, University of California San Diego (UCSD) Health Sciences, San Diego, CA, USA
5Institute of Science and Technology, Federal University of São Paulo (UNIFESP), Sao José dos Campos, SP, Brazil
6Post-graduation Program in Bioengineering, Universidade Brasil, São Paulo, SP, Brazil
7Post-graduation Program in Sciences of Human Movement and Rehabilitation, Federal University of São Paulo (UNIFESP), Santos, SP, Brazil

Correspondence should be addressed to Ana Paula Ligeiro-de-Oliveira; moc.liamg@oriegilpa

Received 28 June 2017; Accepted 9 December 2017; Published 4 March 2018

Academic Editor: Saeid Golbidi

Copyright © 2018 Gabriel da Cunha Moraes et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. D. Lopez and C. C. J. L. Murray, “The global burden of disease, 1990–2020,” Nature Medicine, vol. 4, no. 11, pp. 1241–1243, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. “Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD),” 2017, http://goldcopd.org.
  3. R. A. Pauwels, A. S. Buist, P. M. Calverley, C. R. Jenkins, and S. S. Hurd, “Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary,” American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 5, pp. 1256–1276, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. J. A. Goldman, Investigative Studies of Laser Technology in Rheumatology and Immunology. Biomedical Laser Technology Clinical Applications, Springer Verlag, New York, NY, USA, 1981.
  5. F. M. de Lima, A. B. Villaverde, R. Albertini et al., “Dual effect of low-level laser therapy (LLLT) on the acute lung inflammation induced by intestinal ischemia and reperfusion: action on anti-and pro-inflammatory cytokines,” Lasers in Surgery and Medicine, vol. 43, no. 5, pp. 410–420, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. E. P. Kashanskaia and A. A. Fedorov, “Low-intensity laser radiation in the combined treatment of patients with chronic obstructive bronchitis,” Voprosy Kurortologii, Fizioterapii, i Lechebnoĭ Fizicheskoĭ Kultury, vol. 2, pp. 19–22, 2009. View at Google Scholar
  7. I. S. Landyshev, N. V. Avdeeva, N. D. Goborov, N. P. Krasavina, G. A. Tikhonova, and S. I. Tkacheva, “Efficacy of low intensity laser irradiation and sodium nedocromil in the complex treatment of patients with bronchial asthma,” Terapevticheskiĭ Arkhiv, vol. 74, no. 3, pp. 25–28, 2002. View at Google Scholar
  8. M. J. L. Bours, E. L. R. Swennen, F. Di Virgilio, B. N. Cronstein, and P. C. Dagnelie, “Adenosine 5-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation,” Pharmacology & Therapeutics, vol. 112, no. 2, pp. 358–404, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Burnstock, “Pathophysiology and therapeutic potential of purinergic signaling,” Pharmacological Reviews, vol. 58, no. 1, pp. 58–86, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. J. C. Hogg, “Pathophysiology of airflow limitation in chronic obstructive pulmonary disease,” The Lancet, vol. 364, no. 9435, pp. 709–721, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. J. P. S. Peron, A. A. de Brito, M. Pelatti et al., “Correction: Human tubal-derived mesenchymal stromal cells associated with low level laser therapy significantly reduces cigarette smoke-induced COPD in C57BL/6 mice,” PLoS One, vol. 10, no. 9, article e0139294, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. A. S. Andrade-Sousa, P. R. Pereira, B. A. MacKenzie et al., “Aerobic exercise attenuated bleomycin-induced lung fibrosis in Th2-dominant mice,” PLoS One, vol. 11, no. 9, article e0163420, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. A. C. P. Peres, P. N. Nonaka, P. de Tarso Camillo de Carvalho et al., “Effects of Tityus serrulatus scorpion venom on lung mechanics and inflammation in mice,” Toxicon, vol. 53, no. 7-8, pp. 779–785, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. P. N. Nonaka, C. F. Amorim, A. C. P. Peres et al., “Pulmonary mechanic and lung histology injury induced by Crotalus durissus terrificus snake venom,” Toxicon, vol. 51, no. 7, pp. 1158–1166, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Matute-Bello, C. W. Frevert, and T. R. Martin, “Animal models of acute lung injury,” American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 295, no. 3, pp. L379–L399, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. M. G. Bouma, W. A. Buurman, and F. A. J. M. van den Wildenberg, “Low energy laser irradiation fails to modulate the inflammatory function of human monocytes and endothelial cells,” Lasers in Surgery and Medicine, vol. 19, no. 2, pp. 207–215, 1996. View at Publisher · View at Google Scholar
  17. J.-L. Boulnois, “Photophysical processes in recent medical laser developments: a review,” Lasers in Medical Science, vol. 1, no. 1, pp. 47–66, 1986. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Chen, Y. Li, Z. Zheng, Q. Luo, and R. Chen, “The analysis of components that lead to increased work of breathing in chronic obstructive pulmonary disease patients,” Journal of Thoracic Disease, vol. 8, no. 8, pp. 2212–2218, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Mafra De Lima, M. S. Costa, R. Albertini, J. A. Silva Jr., and F. Aimbire, “Low level laser therapy (LLLT): attenuation of cholinergic hyperreactivity, β2-adrenergic hyporesponsiveness and TNF-α mRNA expression in rat bronchi segments in E. coli lipopolysaccharide-induced airway inflammation by a NF-κB dependent mechanism,” Lasers in Surgery and Medicine, vol. 41, no. 1, pp. 68–74, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Miranda da Silva, M. Peres Leal, R. A. Brochetti et al., “Low level laser therapy reduces the development of lung inflammation induced by formaldehyde exposure,” PLoS One, vol. 10, no. 11, article e0142816, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. V. R. Silva, P. Marcondes, M. Silva et al., “Low-level laser therapy inhibits bronchoconstriction, Th2 inflammation and airway remodeling in allergic asthma,” Respiratory Physiology & Neurobiology, vol. 1, pp. 37–48, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. M. C. Oliveira Jr., F. R. Greiffo, N. C. Rigonato-Oliveira et al., “Low level laser therapy reduces acute lung inflammation in a model of pulmonary and extrapulmonary LPS-induced ARDS,” Journal of Photochemistry and Photobiology B: Biology, vol. 134, pp. 57–63, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. J.-Y. Wu, C.-H. Chen, C.-Z. Wang, M.-L. Ho, M.-L. Yeh, and Y.-H. Wang, “Low-power laser irradiation suppresses inflammatory response of human adipose-derived stem cells by modulating intracellular cyclic AMP level and NF-κB activity,” PLoS One, vol. 8, no. 1, article e54067, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Mortaz, S. Braber, M. Nazary, M. E. Givi, F. P. Nijkamp, and G. Folkerts, “ATP in the pathogenesis of lung emphysema,” European Journal of Pharmacology, vol. 619, no. 1–3, pp. 92–96, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Lommatzsch, S. Cicko, T. Müller et al., “Extracellular adenosine triphosphate and chronic obstructive pulmonary disease,” American Journal of Respiratory and Critical Care Medicine, vol. 181, no. 9, pp. 928–934, 2010. View at Publisher · View at Google Scholar · View at Scopus